Description: Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Home Page: sharpstechnology.com
STSS Technical Analysis
105 Maxess Road
Melville,
NY
11747
United States
Phone:
631-574-4436
Officers
| Name | Title |
|---|---|
| Mr. Alan R. Blackman | Co-Chairman, Chief Investment Officer, COO & Sec. |
| Mr. Robert M. Hayes | CEO & Director |
| Mr. Andrew R. Crescenzo CPA | Chief Financial Officer |
| Mr. Barry B. Berler | Chief Technical Officer & Inventor |
| Dr. Steven Hertz M.D. | Chief Medical Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.3066 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2022-04-14 |
| Fiscal Year End: | December |
| Full Time Employees: | 3 |